Clinical Trial Update: Study to Assess Effectiveness and Safety of Zanubrutinib for Patients With Marginal Zone Lymphoma Treated in Italy Under the Named Patient Program (NPP)

View source ↗

Summary

This clinical trial update describes a study to evaluate the effectiveness and safety of zanubrutinib in Italian patients with marginal zone lymphoma under the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Marginal Zone Lymphoma

Drugs mentioned

• BRUKINSA (ZANUBRUTINIB)

Snippet

Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna | Conditions: Marginal Zone Lymphoma(MZL) | Status: RECRUITING